Expression of carbonic anhydrase 9 at the invasion front of gastric cancers

Gut

Volumn 54, Issue 7, 2005, Pages 920-927

  Chen, J ^b   Rocken C ^a   Hoffmann, J ^b   Kruger S ^a   Lendeckel, U ^a   Rocco, A ^b   Pastorekova, S ^c   Malfertheiner, P ^b   Ebert, M P A ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Otte von Guericke University   (Germany)

^c INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CARBON DIOXIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; CARBONIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CATALYSIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARBONIC ANHYDRASES; CELL PROLIFERATION; FEMALE; HUMANS; ISOENZYMES; MALE; METHYLATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; STOMACH NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 21044434024     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.047340     Document Type: Article

References (34)

1. Parkkila S, Parkkila AK. Carbonic anhydrase in the alimentary tract: Roles of the different isozymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal. Scand J Gastroenterol 1996;31:305-17.
2. Potter CPS, Harris AL. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 2003;89:2-7.
3. Pastorek J, Pastorekova S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbone anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88.
4. Opavsky R, Pastorekova S, Zelnik V, et al. Human MN/Ca9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 1996;33:480-7.
5. Zavada J, Zavadova Z, Pastorekova S, et al. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 1993;54:268-74.
6. Liao SY, Brewer C, Zavada J, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial neoplasia and cervical carcinoma. Am J Pathol 1994;145:598-609.
7. Saarnio J, Parkkila S, Parkkila AK, et al. Immunhistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation, Am J Pathol 1998;153:279-85.
8. Svastova E, Zilka N, Zatovicova M, et al. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with β-catenin. Exp Cell Res 2003;290:332-45.
9. Wykoff CC, Beasley NJP, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60:7075-83.
10. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-regulated carbonic anhydrase-9 (Ca9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 2001;7:3399-403.
11. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001;61:7992-8.
12. Swinson DE, Jones JL, Richardson D, et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia is associated with a poor prognosis in non-small cell lung cancer. J Clin Oncol 2003;21:473-82.
13. Chia SK, Wykoff CC, Watson PH, et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001;19:3660-8.
14. Lancaster JA, Harris AL, Davidson SE, et al. Carbonic anhydrase expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001;61:6394-9.
15. Pastorekova S, Parkkila S, Parkkila AK, et al. Carbonic anhydrase IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997;112:398-408.
16. Leppilampi M, Saarnio J, Karttunen TJ, et al. Carbonic anhydrase isozymes IX and XII in gastric tumors. World J Gastroenterol 2003;9:1398-403.
17. Gut MO, Parkkila S, Vernerova Z, et al. Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology 2002;123:1889-903.
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965;64:31-49.
19. Hamilton SR, Aaltonen LA. WHO classification of tumours. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press, 2000.
20. Ebert MP, Yu J, Hoffmann J, et al. Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 2003;21:1708-14.
21. Juhasz M, Chen J, Lendeckel U, et al. Expression of carbonic anhydrase IX in human pancreatic cancer. Aliment Pharmacol Ther 2003;18:837-46.
22. Krueger S, Buehling F, Kellner U, et al. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype. Cancer Gene Therapy 2001;8:522-8.
23. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995;333:32-41.
24. Ebert M, Malfertheiner P. Pathogenesis of sporadic and familial gastric cancer: Implications for prevention and cancer management. Aliment Pharmacol Ther 2002;16:1059-66.
25. Berx G, Becker KF, Höfler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998;12:226-37.
26. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
27. Stemmermann G, Heffelfinger SC, Noffsinger A, et al. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol 1994;25:968-81.
28. Wingo T, Tu CK, Laipis PJ, et al. The catalytic properties of human carbonic anhydrase IX. Biochem Biophys Res Commun 2001;288:666-9.
29. Ivanov SV, Kuzmin I, Wei MH, et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 1998;95:12596-601.
30. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-75.
31. 2-regulated prolyl hydroxylation. Science 2001;292:468-72.
32. Parkkila S, Rajanieimi H, Parkilla AK, et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000;97:2220-4.
33. Ashida S, Nishimori I, Tanimura M, et al. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma. J Cancer Res Clin Oncol 2002;128:561-8.
34. Cho M, Uemura H, Kim SC, et al. Hypomethylation of the MN/Ca9 promoter and upregulated MN/Ca9 expression in human renal cell carcinoma. Br J Cancer 2001;85:563-7.